Ivím Health
Exact medication listing and a separate provider-level affiliate intake link.
WEEKLY INJECTION COMPARISON
Wegovy vs. Zepbound: compare drugs and full bills
Price verification — October 26, 2026
Some examples and provider price illustrations in this article are estimates, not guaranteed checkout quotes.
- Zepbound (tirzepatide): LillyDirect self-pay: 2.5 mg starts at $299/28 days, 5 mg at $399, and 7.5 mg and above at $449 only with qualifying 45-day refill timing. Higher-dose prices can be higher when those conditions are not met. Supplies may cost extra. Official source
- Wegovy (semaglutide): Wegovy tablet: $149/30 tablets at 1.5 mg, $199 at 4 mg (a temporary $149 4 mg offer may apply), and $299 at 9 mg or 25 mg. Wegovy injection: eligible new patients may pay $199 per 28-day fill for the first two fills at 0.25 or 0.5 mg through Dec. 31, 2026, then generally $349 for standard pen doses. Eligibility and dosage restrictions apply. Official source
These are manufacturer self-pay or listed care-fee examples, not one all-inclusive price or guaranteed prescription. Insurers, clinical visits, pharmacy choice, dosage, supplies, refill conditions and geography can change the amount due.
Injectable semaglutide and tirzepatide are different medications. Compare approved branded products, their own self-pay terms and care arrangements.
Independent medication information · Published prices verified October 25, 2026 · Sponsored links separately labeled
What the medication actually is
Wegovy contains semaglutide; Zepbound contains tirzepatide. Both are prescription weight-management injections, and a clinician should determine the appropriate choice, dose and follow-up plan.
Compare the published facts
| Question | Wegovy injection | Zepbound injection |
|---|---|---|
| Ingredient | Semaglutide | Tirzepatide |
| Manufacturer | Novo Nordisk | Eli Lilly |
| Manufacturer self-pay, starter | New eligible patients: $199 for each of first two qualifying starter fills | 2.5 mg vial / KwikPen starting at $299 for 28 days |
| Manufacturer self-pay, later | $349/month after introductory phase for common weekly pen doses; some formulations differ | 5 mg from $399; 7.5 mg+ from $449 with qualifying refill timing |
| Separate Ivím care fee | $74.99/month | $74.99/month |
| Example Ivím starting total | $273.99/month for qualifying 0.25 mg introductory fill | $373.99/month for 2.5 mg vial |
Review the exact branded listings
Separate destinations: The first link below shows the named medication without commission tracking. The second is an existing affiliate campaign for a provider’s general care program; its landing page may not preselect this medication. Product-level commission attribution is not yet verified.
Sesame Care
Named medication information page and a separate provider-level affiliate intake link.
What to check next: A low promotional starting dose is not a stable long-term estimate. Ask whether the displayed amount applies after titration and whether a separate membership is mandatory.
Sesame billing caveat: The $59/month Success by Sesame care rate is the monthly equivalent of an annual membership currently advertised as $708 billed upfront. The month-to-month care option is advertised at $99/month. Prescription medication is an additional charge, and a separately obtained manufacturer self-pay offer may involve another transaction. Do not treat a $208 monthly-equivalent sum as a guaranteed checkout total or as the first payment.
Cost and medical limitations. All amounts are US public self-pay examples checked October 25, 2026. Prices, access, dose, insurance, taxes, shipping, pharmacy costs and program fees can change. Clinician assessment is required and no prescription is guaranteed. Prescription weight-loss products carry risks and contraindications; review their official prescribing information. Compounded GLP-1 medications are not FDA-approved, and copies of approved drugs face federal restrictions. This website does not diagnose or prescribe.